← SynDRA
diazooxonorleucine
SynDRA canonical compound SYN1970435 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GGT1 | GLS |
| Mechanism of action | glutaminase inhibitor |
| Indication | burkitt's lymphoma |
| Disease area | hematologic malignancy |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 6-diazo-5-oxo-L-norleucine
- L-DON
- L-Norleucine, 6-diazo-5-oxo-
- 6-Diazo-5-oxo-L-nor-Leucine
- L-6-Diazo-5-oxonorleucine
- DON
- NSC 7365
- 03J0H273KZ
- DON (pharmaceutical)
- MFCD00037218
- L-Norleucine,6-diazo-5-oxo-
- BRN 1725815
- Norleucine,6-diazo-5-oxo-
- NSC7365
- (S)-2-Amino-6-diazo-5-oxocaproic acid
- UNII-03J0H273KZ
- AI3-26441
- Norleucine, 6-diazo-5-oxo, L-
- NCIMech_000302
- NCIStruc1_000220
- NCIStruc2_000175
- (L)-DON
- 4-04-00-03278 (Beilstein Handbook Reference)
- CHEMBL97485
- CHEMBL4303391
- Diazo-5-oxo-L-norleucine, 6-
- SCHEMBL15349013
- SCHEMBL15349015
- KMX-010
- NCI7365
- CHEBI:138889
- DTXSID501028846
- EX-A1965
- ZINC3953825
- CCG-35449
- CCG-37571
- NCGC00013078
- AKOS030213039
- NCGC00013078-02
Look up diazooxonorleucine in the interactive SynDRA portal →